Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
  • EVIP - Vaccination portal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • News & events
  • Publications & data
  • Tools
  • About us
  • Search

Search

Filter by
  • Filter by
  • Remove this filter Public health area: Microbiology
  • Infectious disease
    • Vaccine preventable diseases (133)
    • Respiratory diseases (99)
    • Zoonosis (98)
    • Food- and waterborne diseases (97)
    • Tuberculosis (46)
    • Salmonellosis (42)
    • Influenza (42)
    • Sexually transmitted infections (34)
    • Healthcare-associated infections (30)
    • Gonorrhoea (21)
    • Escherichia coli infection (21)
    • Listeriosis (20)
    • Nosocomial infections (19)
    • Viral hepatitis (18)
    • Multidrug-resistant tuberculosis (18)
    • Campylobacteriosis (16)
    • Verocytotoxigenic Escherichia coli (VTEC) infection (15)
    • Verotoxigenic Escherichia coli infection (15)
    • Shiga toxin producing Escherichia coli (STEC) infection (15)
    • Mosquito-borne diseases (15)
    • Influenza in humans, seasonal (14)
    • Zoonotic influenza (14)
    • Seasonal influenza (14)
    • Flu (14)
    • Viral haemorrhagic fever (12)
    • Coronavirus (11)
    • Hepatitis A (11)
    • HIV infection (10)
    • Avian influenza virus (10)
    • Human immunodeficiency virus infection (10)
    • Acquired immunodeficiency syndrome (AIDS) (10)
    • Pertussis (9)
    • Whooping cough (9)
    • Influenza A (H1N1) (8)
    • Hepatitis (8)
    • Emerging disease (8)
    • Drug-resistant tuberculosis (8)
    • Dengue (8)
    • Diphtheria (7)
    • Clostridium difficile infection (7)
    • Pneumococcal disease (7)
    • Enterohaemorrhagic Escherichia coli (EHEC) infection (7)
    • Invasive pneumococcal disease (7)
    • Streptococcus pneumoniae (7)
    • S. pneumoniae (7)
    • COVID-19 (6)
    • SARS-CoV-2 (6)
    • Influenza in humans, swine origin (6)
    • Foodborne diseases (6)
    • Tick-borne diseases (6)
    • Crimean-Congo haemorrhagic fever (5)
    • Middle East respiratory syndrome coronavirus (5)
    • Invasive meningococcal disease (4)
    • Influenza A (H9N2) (4)
    • Avian influenza in humans (4)
    • Swine-origin influenza (4)
    • Yellow fever (4)
    • Haemorrhagic fever (4)
    • Meningococcal disease (4)
    • Influenza in humans, avian origin (4)
    • Zika virus disease (4)
    • Mycobacterium chimaera (3)
    • Klebsiella pneumoniae (3)
    • Influenza A(H5N1) virus (3)
    • Haemophilus influenzae type b (HiB) infection (3)
    • Haemophilus infection (3)
    • Coxsackievirus (3)
    • Carbapenem-resistant Enterobactericae (3)
    • Hepatitis C (3)
    • Hospital-acquired infections (3)
    • Influenza A (H1N1)2009 (3)
    • Invasive Haemophilus influenzae disease (3)
    • Enterovirus (3)
    • Ebola haemorrhagic fever (3)
    • Vector organisms (3)
    • Hepatitis E (3)
    • Methicillin-resistant Staphylococcus aureus (MRSA) (3)
    • Influenza in humans, pandemic (2)
    • Disease vector (2)
    • German measles (2)
    • Guillain-Barré syndrome (2)
    • Congenital rubella (2)
    • Vector-borne disease (2)
    • Extensively drug-resistant tuberculosis (XDR-TB) (2)
    • Chlamydia infection (2)
    • Chikungunya virus disease (2)
    • Measles (2)
    • Rubella (2)
    • Poliomyelitis (2)
    • Hepatitis B (2)
    • Yersiniosis (2)
    • Mosquitoes (1)
    • Ebola outbreak - West Africa (1)
    • Surgical site infections (1)
    • Ventilator-associated pneumonia (1)
    • Extrapulmonary tuberculosis (1)
    • Lymphogranuloma venereum (1)
    • Creutzfeldt-Jakob disease (1)
    • Lyme disease (1)
    • Hydatidosis (1)
    • Borreliosis (1)
    • Acinetobacter (1)
    • Latent tuberculosis infection (1)
    • Arenavirus (1)
    • Zika virus disease - Outbreak in the Americas (1)
    • Syphilis (1)
    • Japanese encephalitis virus (1)
    • Waterborne diseases (1)
    • Severe acute respiratory syndrome (SARS) (1)
    • Rift Valley fever (1)
    • Mumps (1)
    • West Nile virus infection (1)
    • Rabies (1)
    • Variant Creutzfeldt-Jakob disease (vCJD) (1)
    • Echinococcosis (1)
    • Trichinellosis (1)
    • Tularaemia (1)
    • Brucellosis (1)
    • Legionnaires’ disease (1)
    • Q fever (1)
    • Shigellosis (1)
    • Candida auris (1)
  • Public health area
    • Microbiology (549)
    • Molecular typing (108)
    • Surveillance (104)
    • Antimicrobial resistance (64)
    • Antibiotic resistance (64)
    • Prevention and control (58)
    • Disease prevention (57)
    • Prophylaxis (57)
    • Public health threat (56)
    • Outbreak (56)
    • Threats and outbreaks (56)
    • Laboratories (54)
    • Epidemiology (52)
    • Laboratory quality (43)
    • Epidemic (40)
    • Reference laboratory (39)
    • Laboratory based surveillance (39)
    • Diagnostic test (36)
    • National reference laboratory (29)
    • Laboratory capacity (28)
    • Public health response (21)
    • Scientific advice (21)
    • Control campaign (21)
    • Immunisation (19)
    • Vaccination (19)
    • Active immunisation (19)
    • Whole genome sequencing (19)
    • Preparedness (14)
    • Training (13)
    • Biosafety (12)
    • Transmission of disease (11)
    • Laboratory guideline (9)
    • Determinant (8)
    • Antimicrobial consumption (8)
    • Health communication (7)
    • Country cooperation (4)
    • Vaccine safety (4)
    • Epidemic intelligence (3)
    • Risk communication (3)
    • Climate change (3)
    • Migrant health (3)
    • Crisis communication (3)
    • Vaccine effectiveness (3)
    • Pandemic preparedness (2)
    • Preventive measure (2)
    • Vaccine efficacy (2)
    • Antimicrobial stewardship (2)
    • Hospital infection control (2)
    • Antiviral (2)
    • Outbreak communication (1)
    • Public health education (1)
    • Vaccination coverage (1)
    • Travellers' health (1)
    • People who inject drugs (PWID) (1)
    • Infectious diseases on aircrafts (1)
    • Multidrug resistance (1)
    • Intravenous drug users (1)
    • Injecting drug users (IDUs) (1)
    • Pregnant women (1)
    • Vaccine hesitancy (1)
    • Childhood vaccination (1)
  • Country
    • Europe (296)
    • EU Candidate Countries (12)
    • Africa (7)
    • North America (7)
    • Americas (6)
    • European Neighbourhood Policy countries (4)
    • Asia (3)
    • Nothern Africa (2)
    • Pacific regions (1)
  • Media type
    • Publication (287)
    • Peer-reviewed publication (139)
    • Technical report (90)
    • Data (70)
    • Person (69)
    • Map (64)
    • External quality assessment (63)
    • News (38)
    • Event (38)
    • Surveillance report (32)
    • Risk assessment (16)
    • External link (14)
    • Technical guidance (9)
    • Meeting report (7)
    • ECDC comment (6)
    • News story (6)
    • Epidemiological update (4)
    • Tool (4)
    • Corporate publication (2)
    • Systematic review (2)
    • Expert opinion (2)
    • Mission report (1)
    • Public health guidance (1)
    • Press release (1)
    • Campaign (1)
    • Infographic (1)
    • Factsheet (1)
  • Page 1 of 55 // 549 Results found
    • Sort by:

Publication

Sequencing of SARS-CoV-2 - first update

Technical guidance - 18 Jan 2021

This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on which technologies to use and/or in deciding on the role of sequencing for SARS-CoV-2 diagnostics, research, outbreak investigations and surveillance.

Sequencing of SARS-CoV-2 - first update, 18 January 2021 - EN - [PDF-559.12 KB]
  • Coronavirus
  • COVID-19
  • Diagnostic test
  • EU/EEA
  • Laboratories
  • Laboratory based surveillance
  • Microbiology
  • Public health threat
  • Surveillance

Publication

ECDC rapid assessment of laboratory practices and needs related to COVID-19

Technical report - 18 Jan 2021

This report assesses the current status of the EU/EEA and the UK COVID-19 laboratory response based on a short survey sent to all Member States and the UK.

  • Coronavirus
  • COVID-19
  • EU/EEA
  • Laboratories
  • Laboratory capacity
  • Microbiology
  • Public health threat
  • Surveillance

Publication

Ninth external quality assessment scheme for typing of Shiga toxin-producing Escherichia coli

External quality assessment - 5 Nov 2020

This report presents the results of the ninth round of the external quality assessment (EQA-9) scheme for typing of Shiga toxin-producing Escherichia coli (STEC).

Ninth external quality assessment scheme for typing of Shiga toxin-producing Escherichia coli - EN - [PDF-2.64 MB]
  • Escherichia coli infection
  • EU/EEA
  • Laboratory quality
  • Microbiology

Publication

Fourth external quality assessment on species identification and antimicrobial susceptibility testing of Campylobacter, 2018

External quality assessment - 26 Oct 2020

This report presents the results of the fourth round of the EQA on antimicrobial susceptibility testing (AST) for national public health laboratories for Campylobacter (Campylobacter EQA4-AST) within the Food‐ and Waterborne Diseases and Zoonoses Network (FWD-Net). The objectives of this EQA4-AST were to determine the accuracy of quantitative AST results reported by participants; to identify common laboratory problems related to the guidance in the EU protocol, and to assess the overall comparability of routinely collected AST data from national public health reference laboratories across Europe.

Fourth external quality assessment on species identification and antimicrobial susceptibility testing of Campylobacter 2018 - EN - [PDF-1.36 MB]
  • Campylobacteriosis
  • EU/EEA
  • Microbiology

Publication

External quality assessment (EQA) of performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net), 2019

External quality assessment - 15 Oct 2020

This report provides an analysis of the external quality assessment (EQA) for the antimicrobial susceptibility testing (AST) performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2019. A total of 952 laboratories (1–95 per country) from 30 EU/EEA countries participated in the EQA exercise.

External quality assessment (EQA) of performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net), 2019 - EN - [PDF-1.78 MB]
  • Antimicrobial resistance
  • Escherichia coli infection
  • EU/EEA
  • Klebsiella pneumoniae
  • Laboratories
  • Laboratory quality
  • Methicillin-resistant Staphylococcus aureus (MRSA)
  • Microbiology
  • Pneumococcal disease

Publication

EU Laboratory Capability Monitoring System (EULabCap), 2018

Technical report - 29 Sep 2020

This fifth consecutive EULabCap report presents EU/EEA laboratory capabilities and capacities in 2018 and the trends of previous survey results over the period 2013–2018.

EU Laboratory Capability Monitoring System (EULabCap), 2018 - EN - [PDF-3.08 MB]
  • EU/EEA
  • Laboratories
  • Laboratory capacity
  • Microbiology

Event

Retirement symposium on public health microbiology, celebrating the career of Marc Struelens

Event
17 Sep 2020
ECDC
ECDC

Public health microbiology: from managing antimicrobial resistance to COVID-19 - Celebrating the career of Marc Struelens

  • Microbiology

Publication

Third external quality assessment on antimicrobial susceptibility testing and detection of ESBL-, acquired AmpC-, and carbapenemase-production of Salmonella, 2017

External quality assessment - 29 May 2020

This report presents the results of the third round of the external quality assessment (EQA) on antimicrobial
susceptibility testing (AST) for national public health laboratories on Salmonella (hereafter Salmonella EQA3-AST).

Third external quality assessment on antimicrobial susceptibility testing and detection of ESBL-, acquired AmpC-, and carbapenemase-production of Salmonella, 2017 - EN - [PDF-1.14 MB]
  • EU/EEA
  • Microbiology
  • Salmonellosis

Publication

An overview of the rapid test situation for COVID-19 diagnosis in the EU/EEA

Technical report - 1 Apr 2020

According to EU recommendations, timely and accurate COVID-19 laboratory testing is an essential part of the management of COVID-19 for slowing down the pandemic, supporting decisions on infection control strategies and patient management at healthcare facilities, and detecting asymptomatic cases that could spread the virus further if not isolated.

An overview of the rapid test situation for COVID-19 diagnosis in the EU/EEA - EN - [PDF-181.06 KB]
  • Coronavirus
  • COVID-19
  • EU/EEA
  • Laboratories
  • Laboratory capacity
  • Microbiology
  • Public health threat

Data

2018 – Levels of public health microbiology system capabilities and capacities (aggregated EULabCap index)

Map - 17 Dec 2019

17/12/2019

  • Laboratory quality
  • Microbiology

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page ››
  • Last page Last »
  • About us

    • What we do
    • Who we are
    • Governance
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy data
  • Personal data protection
  • Language policy
  • Cookie policy
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2021
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
    • EVIP - Vaccination portal
  • Home
  • All topics: A to Z
  • News & events
  • Publications & data
  • Tools
  • About us